Evaluation of Quadruple Therapy (Pimobendan, Benazepril, Furosemide, Spironolactone) for the Treatment of Dilated Cardiomyopathy (DCM) in Dogs
351 / 67
Authors
-
Ashi.R.Krishna
Ph.D. Scholar, Dept. of Veterinary Clinical Medicine, Madras Veterinary College, Chennai, 600007
-
K. Jeyaraja
Professor, Dept. of Veterinary Clinical Medicine, Madras Veterinary College, Chennai, 600007
-
R. Ramprabhu
Professor, Dept. of Veterinary Clinical Medicine, Madras Veterinary College, Chennai, 600007
-
S. Eswari
Professor and Head, Center for Stem Cell Research and Regenerative Medicine, Madras Veterinary College, Chennai, 600007
-
Mohamed Shafiuzama
Professor and Head, Dept. of Veterinary Surgery and Radiology, Madras Veterinary College, Chennai, 600007
-
S. Kavitha
Professor and Head, Dept. of Veterinary Clinical Medicine, Madras Veterinary College, Chennai, 600007
Keywords:
Dilated cardiomyopathy, dogs, systolic function, echocardiographyAbstract
Dilated cardiomyopathy is a common cardiac disease which affects larger breeds of dogs. The present study evaluated the occurrence of DCM in 10 dogs, its treatment and the treatment response. Ten dogs presented to the Medicine Outpatient unit of Madras Veterinary College Hospital presented with the clinical signs suggestive of DCM formed the study group. The animals were undergone general clinical examination, complete haematology, serum biochemistry, electrocardiography, thoracic radiography and echocardiography. Treatment was initiated with oral pimobendan, benazepril, diuretics and cardiac supportives. The cases showed substantial improvement after three months of treatment.
Downloads
References
Abbott-Johnson, K., Pierce, K.V., Roof, S., Rio, C.L.D. and Hamlin, R. (2021). Acute Effects of Pimobendan on Cardiac function in Dogs with Tachycardia Induced Dilated Cardiomyopathy: a randomized, Placebo-Controlled, crossover study. Front. Vet. Sci. 8: 1-12.
Aparna, G.P.(2021). Pulsed tissue doppler imaging (tdi) in the assessment of left ventricular function in dogs with acquired heart disease. M.V.Sc thesis, Tamil Nadu Veterinary and Animal Sciences university, Chennai.
Bell, E.T., Devi, J.L., Chiu, S., Zahra, P. and Whittem, T. (2016). The pharmacokinetics of pimobendan enantiomers after oral and intravenous administration of racemate pimobendan formulations in healthy dogs. J. Vet. Pharmacol. Ther. 39 : 54–61.
Boon, J.A.(2011). Veterinary echocardiography. 2nd edn. John Wiley & Sons. United Kingdom. pp 139-205.
Boswood, A., Häggström, J., Gordon, S.G., Wess, G., Stepien, R.L., Oyama, M.A., Keene, B.W., Bonagura, J., MacDonald, K.A., Patteson, M., Smith, S., Fox, P.R., Sanderson, K., Woolley, R., Szatmári, V., Menaut, P., Church, W.M., O’Sullivan, M.L., Jaudon, J.P., Kresken, J.G., Rush, J., Barrett, K.A., Rosenthal, S.L., Saunders, A.B., Ljungvall, I., Deinert, M., Bomassi, E., Estrada, A.H., Fernandez Del Palacio, M.J., Moise, N.S., Abbott, J.A., Fujii, Y., Spier, A., Luethy, M.W., Santilli, R.A., Uechi, M., Tidholm, A. and Watson, P. (2016). Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC study—a randomized clinical trial. J. Vet. Intern. Med. 30(6) :1765–1779.
Buchanan, J.W. and Bucheler, J. (1995). Vertebral scale system to measure canine heart size in radiographs. J. Am. Vet. Med. Assoc. 206 : 194-199.
Cheng, K., Malliaras, K., Li, T.S., Sun, B., Houde, C., Galang, G., Smith, J., Matsushita, N. and Marbán, E. (2012). Magnetic enhancement of cell retention, engraftment and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 21: 1121–1135.
Cobb.M.A. (1992). Idiopathic dilated cardiomyopathy: advances in aetiology, pathogenesis and management. J. Small Anim. Pract. 33: 113-118.
Gasparini, S., S. Fonfara, S. Kitz, U. Hetzel and A. Kipar. (2020). Canine dilated cardiomyopathy: diffuse remodeling, focal lesions, and the involvement of macrophages and new vessel formation. Vet. Pathol. 57(3) : 397-408.
Häggström, J., Boswood, A., O'Grady, M., Jöns, O., Smith, S., Swift, S., Borgarelli, M., Gavaghan, B., Kresken, J.G., Patteson, M. and Åblad, B.(2013). Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study. J. Vet. Intern. Med. 27(6): 1441-1451.
Haritha, G.S., S.K.Kumar and A.V.V.V. Kumar. (2020). Management of dilated cardiomyopathy with enalapril and losartan. Adv. Anim. Vet. Sci.8(7) : 777- 781.
Jeyaraja, K., A. Arun, Y.S. Hamsa, P.S.L. Sesh and A.P. Nambi. (2015). Diagnostic evaluation of dilated cardiomyopathy in Labrador Retrievers. Int. J. Adv. Res. 3(12) : 628-655.
Jeyaraja, K., Yamini, S.H. and Chandrasekaran, D. 2019. A Retrospective Analysis of Dilated Cardiomyopathy in Labrador Retrievers. J. Anim. Res. 9(5) : 707-714.
Kanno, N., Kuse, H., Kawasaki, M., Hara, A., Kano, R. and Sasaki, Y. (2007). Effects of pimobendan for mitral valve regurgitation in dogs. J. Vet. Med. Sci. 69 : 373–377.
Kittleson, M.D., Keene, B., Pion, P.D. and Loyer, C.G. (1997). Results of the multicenter spaniel trial (MUST): taurine-and carnitine-responsive dilated cardiomyopathy in American Cocker Spaniels with decreased plasma taurine concentration. J. Vet. Intern. Med. 11(4) : 204-211.
Kramer, G.A., Kittleson, M.D., Fox, P.R., Lewis, J. and Pion, P.D. (1995). Plasma taurine concentrations in normal dogs and in dogs with heart disease. J. Vet. Intern. Med. 9(4) : 253-258.
Little, W.C.(2005). Diastolic dysfunction beyond distensibility: adverse effects of ventricular dilatation. Circulation. 112(19) : 2888-2890.
Martin, M.W.S., Stafford, Johnson, M.J. and Celona, B. (2009). Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases. J. Small Anim. Pract. 50(1) : 23-29.
Martin, M.W.S, .Stafford, M.J., Strehlau, G and King, J.N. (2010). Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases J. Small Anim. Pract. 51 : 428–436.
Meurs, K.M., Lahmers, S., Keene, B.W., White, S.N., Oyama, M.A., Mauceli, E. and Lindblad-Tohet, K. (2012). A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher. Hum Genet. 131(8) : 1319-1325.
Oyama, M.A., Chittur, S.V. and Reynolds, C.A. (2009). Decreased triadin and increased calstabin2 expression in Great Danes with dilated cardiomyopathy. J. Vet. Intern. Med. 23(5) : 1014-1019.
Purvey, M. and Allen, G. (2017). Managing acute pulmonary oedema. Aust. Prescr. 40(2) : 59.
Sández, I., Redondo, J.I., Donati, P.A. and Gómez, J.(2023). Haemodynamic Effects of Pimobendan during General Anaesthesia in Healthy Senior Dogs: A Prospective, Randomised, Triple-Blinded, Placebo-Controlled Clinical Study. Animals 13(13) : 2110.
Sergeev, D., Kovalev, S., Trushkin, V., Vasilev, R., Nikitina, A., Kiselenko, P., Konoplev, V. and Tuvargiev, A.(2021). Use of high doses of pimobendan in animals with dilated cardiomyopathy. The FASEB Journal : 35(S1).
Simpson, S., Dunning, M.D., Brownlie, S., Patel, J., Godden, M., Cobb,M., Mongan, N.P. and Rutland, C.S. (2016). Multiple genetic associations with Irish Wolfhound dilated cardiomyopathy. Bio. Med. Res. Intl. 2016 : 1-14.
Sisson, D.D. and Thomas, W.P. (1995). Myocardial disease. In: Textbook of Veterinary Internal Medicine 4th edn.,Ed: S.J. Ettinger, W.B. Saunders, Philadelphia. pp 99-1005.
Srivastava, M., A. Ahuja, R.D. Velhankar, D.K. Bihani, A. Chahar, R.V. Gaikwad, H. Dhadich, S.K. Kashyap, S. Kacchawaha and P. Khangal.(2015). Cardiorenal syndrome in dilated cardiomyopathy of dogs. Ind. Jour. Can. Pract. 7(2) : 94.
Summerfield, N.J., Boswood, A., O'Grady, M.R., Gordon, S.G., Dukes McEwan, J., Oyama, M.A., Smith, S., Patteson, M., French, A.T., Culshaw, G.J. and Braz Ruivo, L. (2012). Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman pinschers with preclinical dilated cardiomyopathy (The PROTECT Study). J. Vet. Intern. Med. 26(6) : 1337-1349.
Suzuki S, Fukushima R, Ishikawa T, Hamabe L, Aytemiz D, and Huai-Che H. (2011) The effect of pimobendan on left atrial pressure in dogs with mitral valve regurgitation. J. Vet. Intern. Med. 25(6) : 1328–1333.
Wess, G. and M. Torti.(2018). Arrhythmias in canine cardiomyopathies and valvular heart disease. In. Guide to canine and feline electrocardiography, 1st end., Ed: Willis, R., Oliveira, P. and Mavropoulou, A., John Wiley & Sons Ltd, Oxford, United Kingdom pp 285-300.
Wess, G, (2022). Screening for dilated cardiomyopathy in dogs. J. Vet. Cardiol. 40 : 51-68.
Yata, M., McLachlan, A.J., Foster, D.J., Page, S.W. and Beijerink, N.J. (2016). Pharmacokinetics and cardiovascular effects following a single oral administration of a nonaqueous pimobendan solution in healthy dogs. J. Vet. Pharmacol. Ther. 39 : 45–53.
